Low molecular weight hyaluronic acid effects on murine macrophage nitric oxide production

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 3, 2010, Pages 893-904

  Lyle, Daniel B ^a   Breger, Joyce C ^a,b   Baeva, Larissa F ^a   Shallcross, Jonathan C ^a   Durfor, Charles N ^a   Wang, Nam Sun ^b   Langone, John J ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Biomaterials; Hyaluronic acid; Inflammation; Macrophage; Nitric oxide

Indexed keywords

ADVERSE EVENTS; CELL LINES; CHEMICAL STRUCTURE; CHRONIC INFLAMMATION; DATA SUPPORT; HYALURONIC ACID; HYALURONIC ACIDS; INFLAMMATION; INFLAMMATORY CONDITIONS; INFLAMMATORY REACTION; LOW LEVEL; LOW MOLECULAR WEIGHT; MEDICAL DEVICES; MICROMOLAR CONCENTRATION; MURINE MACROPHAGES; NORMAL TISSUE; SHORT TERM; SPLENOCYTES;

BIOLOGICAL MATERIALS; BIOMATERIALS; BIOMEDICAL ENGINEERING; CELL CULTURE; MACROPHAGES; MOLECULAR WEIGHT; ORGANIC ACIDS; PATHOLOGY;

NITRIC OXIDE;

CONCANAVALIN A; ENDOTOXIN; HYALURONIC ACID; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRITE; OLIGOSACCHARIDE; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; INFLAMMATION; MACROPHAGE; MOLECULAR WEIGHT; NONHUMAN; RAT; SPLEEN CELL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE; HUMANS; HYALURONIC ACID; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MACROPHAGES; MATERIALS TESTING; MICE; MOLECULAR WEIGHT; NITRIC OXIDE; RATS; SPLEEN;

EID: 77954790281     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32760     Document Type: Article

References (85)

1. Camillieri G, Nastasi A, Gulino P, Bucolo C, Drago F. Effects of hyaluronan on free-radical formation, corneal endothelium damage, and inflammation parameters after phacoemulsification in rabbits. J Ocul Pharmacol Ther 2004;20:151-157.
2. Balazs EA. Hyaluronan as an ophthalmic viscoelastics device. Curr Pharm Biotechnol 2008;9:236-238.
3. Calciu-Rusu D, Rothfuss E, Eckelt J, Haase T, Dick HB, Wolf BA. Rheology of sodium hyaluronate saline solutions for ophthalmic use. Biomacromolecules 2007;8:1287-1292.
4. Carruthers A, Carruthers J. Non-animal-based hyaluronic acid fillers: Scientific and technical considerations. Plast Reconstr Surg 2007;120:33S-40S.
5. Clark CP. Animal-based hyaluronic acid fillers: Scientific and technical considerations. Plast Reconstr Surg 2007;120:27S-32S.
6. Migliore A, Granata M. Intra-articular use of hyaluronic acid in the treatment of osteoarthritis. Clin Interv Aging 2008;3:365-369. (Pubitemid 352037875)
7. Conrozier T, Chevalier X. Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis. Expert Opin Pharmacother 2008;9:1797-1804.
8. Kelly MA, Moskowitz RW, Lieberman JR. Hyaluronan therapy: Looking towards the future. Am J Orthop 2004;33:23-28.
9. Kerscher M, Bayrhammer J, Reuther T. Rejuvenating influence of a stabilized hyaluronic acid-based gel of nonanimal origin on facial skin aging. Dermatol Surg 2008;34:720-726.
10. Wiest L, Kerscher M. Native hyaluronic acid in dermatology - Results of an expert meeting. J Dtsch Dermatol Ges 2008;6:176-180.
11. Hosack LW, Firpo MA, Scott JA, Prestwich GD, Peattie RA. Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels. Biomaterials 2008;29:2336-2347.
12. Yadav AK, Mishra P, Agrawal GP. An insight on hyaluronic acid in drug targeting and drug delivery. J Drug Target 2008;16:91-107.
13. Bourguignon LYW, Peyrollier K, Xia W, Gilad E. Hyaluronan-CD44 interaction activates stem cell marker nanog, stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 2008;283:17635-17651.
14. Goodstone NJ, Cartwright A, Ashton B. Effects of high molecular weight hyaluronan on chondrocytes cultured within a resorbable gelatin sponge. Tissue Eng 2004;10:621-631.
15. Aigner J, Tegeler J, Hutzler P, Campoccia D, Pavesio A, Hammer C, Kastenbauer E, Naumann A. Cartilage tissue engineering with novel nonwoven structured biomaterial based on hyaluronic acid benzyl ester. J Biomed Mater Res 1998;42:172-181.
16. Yung S, Chan TM. Hyaluronan - Regulator and initiator of peritoneal inflammation and remodeling. Int J Artif Org 2007;30:477-483. (Pubitemid 47249124)
17. Fedorovich NE, Oudshoorn MH, van Geemen D, Hennink WE, Alblas J, Dhert WJ. The effect of photopolymerization on stem cells embedded in hydrogels. Biomaterials 2009;30:344-353.
18. Khademhosseini A, Eng G, Yeh J, Fukuda J, Blumling J III, Langer R, Burdick JA. Micromolding of photocrosslinkable hyaluronic acid for cell encapsulation and entrapment. J Biomed Mater Res A 2006;79:522-532.
19. Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther 2008;10:35-42.
20. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008;34:S92-S99.
21. Judodihardjo H, Dykes P. Objective and subjective measurements of cutaneous inflammation after a novel hyaluronic acid injection. Dermatol Surg 2008;34:S110-S114.
22. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007;33:S168-S175.
23. Filion MC, Phillips NC. Pro-inflammatory activity of contaminating DNA in hyaluronic acid preparations. J Pharm Pharmacol 2001;53:555-561.
24. Jiang D, Liang J, Nobel PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007;23:435-461.
25. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006;177:1272-1281.
26. Powell JD, Horton MR. Threat matrix: Low-molecular-weight hyaluronan as a danger signal. Immunol Res 2005;32:207-218.
27. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: An information-rich system. Eur J Cell Biol 2006;85:699-715.
28. Kim C, Park E, Quinn MR, Schuller-Levis G. The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-alpha in the conditioned media is inhibited by taurine chloramine. Immunopharmacology 1996;34:89-95.
29. Kanj RS, Kang JL, Castranova V. Measurement of the release of inflammatory mediators from rat alveolar macrophages and alveolar type II cells following lipopolysaccharide or silica exposure: A comparative study. J Toxicol Environ Health A 2005;68:185-207.
30. Pendino KJ, Laskin JD, Shuler RL, Punjabi CJ, Laskin DL. Enhanced production of nitric oxide by rat alveolar macrophages after inhalation of a pulmonary irritant is associated with increased expression of nitric oxide synthase. J Immunol 1993;151:7196-71205.
31. Rafi-Janajreh AQ, Nagarkatti PS, Nagarkatti M. Role of CD44 in CTL and NK cell activity. Front Biosci 1998;3:665-671.
32. Stein CS, Strejan GH. Rat splenocytes inhibit antigen-specific lymphocyte proliferation through a reactive nitrogen intermediate (RNI)-dependent mechanism and exhibit increased RNI production in response to IFN-γ. Cellular Immunol 1993;150:281-297.
33. Nicolau PJ. Long-lasting and permanent fillers: Biomaterial influence over host tissue response. Plast Reconstr Surg 2007;119:2271-2286.
34. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993;214:11-16.
35. Le Page C, Sanceau J, Drapier JC, Wietzerbin J. Differential expression of inducible NO synthase in two murine macrophage cell lines. Immunology 1996;89:274-280. (Pubitemid 26340134)
36. Kawabe T, Isobe KI, Hasegawa Y, Nakashima I, Shimokata K. Immunosuppressive activity induced by nitric oxide in culture supernatant of activated rat alveolar macrophages. Immunology 1992;76:72-78.
37. Lemaire I, Yang H, Lauzon W, Gendron N. M-CSF and GM-CSF promote alveolar macrophage differentiation into multinucleated giant cells with distinct phenotypes. J Leukoc Biol 1996;60:509-518.
38. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, Simon JC. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000;165:1863-1870.
39. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002;195:99-111.
40. Breborowicz A, Polubinska A, Moberly J, Ogle K, Martis L, Oreopoulos D. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats. Am J Kidney Dis 2001;37:594-600.
41. Nakamura K, Yokohama S, Yoneda M, Okamoto S, Tamaki Y, Ito T, Okada M, Aso K, Makino I. High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice. J Gastroenterol 2004;39:346-354.
42. Schimizzi AL, Massie JB, Murphy M, Perry A, Kim CW, Garfin SR, Akeson WH. High-molecular weight hyaluronan inhibits macrophage proliferation and cytokine release in the early wound of a preclinical postlaminectomy rat model. Spine J 2006;6:550-556. (Pubitemid 44261709)
43. Sheehan KM, DeLott LB, Day SM, DeHeer DH. Hyalgan has a dose-dependent differential effect on macrophage proliferation and cell death. J Orthop Res 2003;21:744-751.
44. Yasuda T. Hyaluronan inhibits cytokine production by lipopolysaccharide- stimulated U937 macrophages through down-regulation of NF-κβ via ICAM-1. Inflamm Res 2007;56:246-253.
45. Mummert ME. Immunologic roles of hyaluronan. Immunol Res 2005;31:189-205.
46. McDonald B, McAvoy EF, Lam F, Gill V, de la Motte C, Savani RC, Kubes P. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med 2008;205:915-927.
47. Roth A, Mollenhauer J, Wagner A, Fuhrmann R, Straub A, Venbrocks RA, Petrow P, Brauer R, Schubert H, Ozegowski J, Peschel G, Muller PJ, Kinne RW. Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis. Arthritis Res Ther 2005;7:R677-R686.
48. Wang M-J, Kuo J-S, Lee W-W, Huang H-Y, Chen W-F, Lin S-Z. Translational event mediates differential production of tumor necrosis factor-α in hyaluronan-stimulated microglia and macrophages. J Neurochem 2006;97:857-871.
49. Horton MR, Shapiro S, Bao C, Lowenstein CJ, Nobel PW. Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J Immunol 1999;162:4171-4176. (Pubitemid 29314803)
50. Horton MR, Burdick MD, Strieter RM, Bao C, Nobel PW. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophages. J Immunol 1998;160:3023-3030. (Pubitemid 28136759)
51. Horton MR, Boodoo S, Powell JD. NF-κβ activation mediates the cross-talk between extracellular matrix and interferon-γ (IFN-γ) leading to enhanced monokine induced by IFN-γ (MIG) expression in macrophages. J Biol Chem 2002;277:43757-43762.
52. Horton MR, McKee CM, Bao C, Liao F, Farber JM, Hodge-DuFour J, Pure E, Oliver BL, Wright TM, Noble PW. Hyaluronan fragments synergize with interferon-c to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem 1998;273:35088-35094.
53. Tabata T, Mine S, Okada Y, Tanaka Y. Low molecular weight hyaluronan increases the uptaking of oxidized LDL into monocytes. Endocr J 2007;54:685-693.
54. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. J Clin Invest 1996;98:2403-2413.
55. Gariboldi S, Palazzo M, Zanobbio L, Selleri S, Sommariva M, Sfondrini L, Cavicchini S, Balsari A, Rumio C. Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of β-defensin 2 via TLR2 and TLR4. J Immunol 2008;181:2103-2110.
56. Mascarenhas MM, Day RM, Ochoa CD, Choi W-I, Yu L, Quyang B, Garg HG, Hales CA, Quinn DA. Low molecular weight hyaluronan from stretched lung enhances interleukin-8 expression. Am J Respir Cell Mol Biol 2004;30:51-60.
57. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004;279:17079-17084.
58. Haslinger B, Mandl-Weber S, Sellmayer A, Sitter T. Hyaluronan fragments induce the synthesis of MCP-1 and IL-8 in cultured human peritoneal mesothelial cells. Cell Tissue Res 2001;305:79-86.
59. Ohno S, Im H-J, Knudson CB, Knudson W. Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFκβ and p38 MAP kinase in articular chondrocytes. J Biol Chem 2006;281:17952-17960.
60. Fujii K, Tanaka Y, Hubscher S, Saito K, Ota T, Eto S. Cross-linking of CD44 on rheumatoid synovial cells up-regulates VCAM-1. J Immunol 1999;162:2391-2398. (Pubitemid 29288867)
61. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, Henson PM, Noble PW. Resolution of lung inflammation by CD44. Science 2002;296:155-158.
62. Hodge-Dufour J, Noble PW, Horton MR, Bao C, Wysoka M, Burdick MD, Strieter RM, Trinchieri G, Pure E. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol 1997;159:2492-2500.
63. Joddar B, Ramamurthi A. Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells. Biomaterials 2006;27:2994-3004. (Pubitemid 43208925)
64. Tsujimura S, Saito K, Kohno K, Tanaka Y. Fragmented hyaluronan induces transcriptional up-regulation of the multidrug resistance-1 gene in CD4+ T cells. J Biol Chem 2006;281:38089-38097.
65. Alaniz L, Garcia MG, Gallo-Rodriguez C, Agusti R, Sterin-Speziale N, Hajos SE, Alvarez E. Hyaluronan oligosaccharides induce cell death through P13-K/Akt pathway independently of NF-κβ transcription factor. Gycobiology 2006;16:359-367.
66. Gao F, Cao M, Yang C, He Y, Liu Y. Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study. J Biomed Mater Res Part B 2006;78:385-392.
67. Chajara A, Raoudi M, Delpech B, Levesque H. Inhibition of arterial cells proliferation in vivo in injured arteries by hyaluronan fragments. Atherosclerosis 2003;171:15-19.
68. Habara T, Nakatsuka M, Konishi H, Asagiri K, Noguchi S, Kudo T. The biological effects of antiadhesion agents on activated RAW264.7 macrophages. J Biomed Mater Res A 2002;61:628-633. (Pubitemid 34721507)
69. Ariyoshi W, Takahashi T, Kanno T, Ichimiya H, Takano H, Koseki T, Nishihara T. Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid. J Biol Chem 2005;280:18967-18972.
70. Noble PW, McKee CM, Cowman M, Shin HS. Hyaluronan fragments activate an NF-κβ/I-κβα autoregulatory loop in murine macrophages. J Exp Med 1996;183:2372-2378.
71. McKee CM, Lowenstein CJ, Horton MR, Wu J, Bao C, Chin BY, Choi AMK, Noble PW. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor κβ-dependent mechanism. J Biol Chem 1997;272:8013-8018.
72. Maneiro E, de Andres MC, Fernandez-Sueiro JL, Galdo F, Blanco FJ. The biological action of hyaluronan on human osteoarthritic articular chondrocytes: The importance of molecular weight. Clin Exp Rheumatol 2004;22:307-312. (Pubitemid 38585233)
73. Takahashi T, Tominaga K, Takano H, Ariyoshi W, Habu M, Fukuda J, Maeda H. A decrease in the molecular weight of hyaluronic acid in synovial fluid from patients with temporomandibular disorders. J Oral Pathol Med 2004;33:224-229.
74. Wang M-J, Jeng K-CG, Kuo J-S, Chen H-L, Huang H-Y, Chen W-F, Lin S-Z. c-Jun n-terminal kinase and, to a lesser extent, p38 mitogen-activated protein kinase regulate inducible nitric oxide synthase expression in hyaluronan fragments-stimulated BV-2 microglia. J Neuroimmunol 2004;146:50-62.
75. Fioravanti A, Cantarini L, Chellini F, Manca D, Paccagnini E, Marcolongo R, Collodel G. Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure. Osteoarthritis Cartilage 2005;13:688-696.
76. Ghosh P, Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: Are the effects molecular weight dependent? Semin Arthritis Rheum 2002;32:10-37.
77. Gao C, Guo H, Wei J, Kuo PC. Osteopontin inhibits expression of cytochrome c oxidase in RAW 264.7 murine macrophages. Biochem Biophys Res Commun 2003;309:120-125.
78. Sheehan KM, DeLott LB, West RA, Bonnema JD, DeHeer DH. Hyaluronic acid of high molecular weight inhibits proliferation and induces cell death in U937 macrophage cells. Life Sci 2004;75:3087-3102.
79. Vitanzo PC, Sennett BJ. Hyaluronans: Is clinical effectiveness dependent on molecular weight? Am J Orthop 2006;35:421-428.
80. Diks SH, van Deventer SJ, Peppelenbosch MP. Lipopolysaccharide recognition, internalization, signaling and other cellular effects. J Endotoxin Res 2001;7:335-348.
81. Bhattacharyya J, Biswas S, Datta AG. Mode of action of endotoxin: Role of free radicals and antioxidants. Curr Med Chem 2004;11:359-368.
82. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002;71:635-700.
83. Lyle DB, Shallcross JC, Durfor CN, Hitchins VM, Breger JC, Langone JJ. Screening biomaterials for stimulation of nitric oxide-mediated inflammation. J Biomed Mater Res A 2008;90:82-93.
84. Breger JC, Lyle, DB, Shallcross JC, Langone JL, Wang NS. Defining critical inflammatory parameters for endotoxin impurity in manufactured alginate microcapsules. J Biomed Mater Res B Appl Biomater 2009;91:755-765.
85. Cooperstock MS. Inactivation of endotoxin by polymyxin B. Antimicrob Agents Chemother 1974;6:422-425.